Clal Biotechnology reported ILS1.61M in Ordinary Share Capital for its fiscal quarter ending in December of 2022.


Ordinary Share Capital Change Date
Clal Biotechnology ILS 1.61M 0 Dec/2022
Compugen USD 93.54M 93.29M Jun/2025
Life Technologies USD 92.87M 92.79M Jun/2025
RedHill Biopharma USD 34.78M 13.34M Jun/2024